Stable modifications to the expression of neurohormones in the rat hypothalamus in a model of post-traumatic stress disorder

Neuroscience and Behavioral Physiology

Volumn 40, Issue 1, 2010, Pages 111-115

  Mironova, V I ^a   Rybnikova, E A ^a  

^a PAVLOV INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Corticoliberin; Hypothalamus; Post traumatic stress disorder; Stress restress model; Vasopressin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROHORMONE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; RAT; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, WISTAR; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS; VASOPRESSINS;

EID: 77949373366     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-009-9216-5     Document Type: Article

References (28)

1. V. M. Voloshin, Post-Traumatic Stress Disorder. Phenomenology, Clinical Aspects Systematics, Dynamics, and Contemporary Approaches to Psychopharmacotherapy [in Russian], Anakharsis, Moscow (2005).
2. A. L. Pushkarev, V. A. Domoratskii, and E. G. Gordeeva, Post- Traumatic Stress Disorder: Diagnosis, Psychopharmacotherapy, Psychotherapy [in Russian], Institute of Psychotherapy Press, Moscow (2000).
3. M. V. Ugryumov, Mechanisms of Neuroendocrine Regulation [in Russian], Nauka, Moscow (1999).
4. V. G. Shalyapina, "Corticoliberin in the regulation of adaptive behavior in the pathogenesis of post-stress depression," in: Basic Neuroendocrinology [in Russian], V. G. Shalyapina and P. D. Shabanov (eds.), ÉLBI, St. Petersburg (2005), pp. 84-146.
5. K.-B. Abel and J. A. Majzoub, "Molecular biology of the HPA axis," in: Handbook of Stress and the Brain, T. Steckler, N. H. Kalin, and J. M. H. M. Reul (eds.), Elsevier, Amsterdam (2005), pp. 79-95.
6. G. Aguilera and C. Rabadan-Deihl, "Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation," Regul. Pept., 96, 23-29 (2000).
7. R. H. Belmaker and G. Agam, "Major depressive disorder: mechanisms of disease," New. Engl. Med. J., 358, No. 1, 55-68 (2008).
8. G. D. Bremner, I. Licono, and A. Darnell, "Elevated corticotrophin-releasing factor concentration in posttraumatic stress disorders," Am. J. Psychiatry, 154, No. 5, 624-629 (1997).
9. C. S. de Kloet, E. Vermetten, E. Geuze, E. G. Lentjes, C. J. Heijnen, G. K. Stalla, and H. G. Westenberg, "Elevated plasma corticotrophin- releasing hormone levels in veterans with posttraumatic stress disorder," Prog. Brain Res., 167, 287-291 (2007).
10. C. S. De Kloet, E. Vermetten, C. J. Heijnen, E. Geuze, E. G. Lentjes, and H. G. Westenberg, "Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder," Psychoneuroendocrinology, 32, No. 3, 215-226 (2007).
11. E. B. De Souza and D. E. Grigoriadis, "Corticotropin-releasing factor: physiology, pharmacology, and role in central nervous system disorders," in: Neuropsychopharmacology: The Fifth Generation of Progress, K. L. Davis, J. T. Charney, J. T. Coyle, and C. Nemeroff (eds.), American College of Neuropsychopharmacology (2002), Chapter 7, pp. 91-107.
12. A. J. Douglas, "Vasopressin and oxytocin," in: Handbook of Stress and the Brain. Part 1. The Neurobiology of Stress, N. H. Steckler, N. H. Kalin, and J. M. H. M. Reul (eds.), Elsevier, Amsterdam, etc. (2005), pp. 205-230.
13. B. H. Harvey, C. Naciti, L. Brand, and D. J. Stein, "Endocrine, cognitive and hippocampal/cortical 5HT1A/2A receptor changes evoked by a time-dependent sensitisation (IDS) stress model in rats," Brain Res., 983, 97-107 (2003).
14. F. Holsboer, "Corticotropin-releasing hormone modulators and depression," Curr. Opin. Investig. Drugs, 4, 46-50 (2003).
15. F. Holsboer, "Neuroendocrinology of mood disorders," in: Psychopharmacology: the Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer (eds.), Raven Press, New York (1995), Chapter 83, pp. 957-970.
16. J. W. Kaskow, D. Baker, and T. D. Geracioti, "Corticotropin- releasing hormone in depression and post-traumatic stress disorder," Peptides, 22, 845-851 (2001).
17. I. Liberzon, M. Krstov, and E. A. Young, "Stress-restress: effects on ACTH and fast feedback," Psychoneuroendocrinology, 26, 443-453 (1997).
18. M. Olff, Y. Güzelcan, G. J. De Vries, J. Assies, and B. P. Gersons, "HPA- and HPT-axis alterations in chronic posttraumatic stress disorder," Psychoneuroendocrinology, 31, No. 10, 1220-1230 (2006).
19. M. A. Oquendo, G. Echavarria, H. C. Galfalvy, M. F. Grunebaum, I. Burke, A. Barrera, T. B. Cooper, K. M. Malone, and J. J. Mann, "Lower cortisol levels in depressed patients with comorbid posttraumatic stress disorder," Neuropsychopharmacology, 28, 591-598 (2003).
20. M. Owens and C. B. Nemeroff, "Physiology and pharmacology of corticotropin-releasing factor," Pharmacol. Rev., 43, No. 4, 425-473 (1991).
21. P. H. Rosebloom, N. H. Kalin, T. Steckler, and F. M. Dautzenberg, "Molecular regulation of the CRF system," in: Handbook of Stress and the Brain. Part 1. The Neurobiology of Stress, T. Steckler, N. H. Kalin, and J. M. H. M. Reul (eds.), Elsevier, Amsterdam, etc. (2005), Vol. 15, pp. 133-152.
22. L. Scott and T. G. Dinan, "Vasopressin as a target for antidepressant development: an assessment of available evidence," J. Affect. Disord., 72, 113-124 (2002).
23. D. Simeon, M. Knutelska, R. Yehuda, F. Putnam, J. Schmeidler, and L. M. Smith, "Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers," Biol. Psychiatry, 61, No. 8, 966-973 (2007).
24. G. N. Smagin, S. C. Heinrics, and A. J. Dunn, "The role of CRH in behavioral responses to stress," Peptides, 22, 713-724 (2001).
25. J. D. K. Uys, D. J. Stein, W. M. U. Daniels, and B. H. Harvey, "Animal models of anxiety disorders," Curr. Psychiat. Rep., 5, 274-281 (2003).
26. L. Weisaeth, "Vulnerability and protective factors for posttraumatic stress disorder," Psychiat. Clin. Neurosci., 52, No. 5, 83-88 (1998).
27. R. Yehuda, "Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications," Ann. N.Y. Acad. Sci., 1071, 137-156 (2006).
28. R. Yehuda and S. M. Antelman, "Criteria for evaluating animal models of post traumatic stress disorder," Biol. Psychiat., 33, 479-486 (1993).